Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$11.36
-4.22%
Mkt Cap $794.98M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (3 analysts)
$22.50
Range $22.00 – $23.00
Implied Upside
+98.1%
Consensus $22.50 vs current $11.36
NASDAQ·Healthcare·Biotechnology
$11.36
-4.22%
Mkt Cap $794.98M
Buy
2
Hold
1
Sell
0
Price Target (3 analysts)
$22.50
Range $22.00 – $23.00
+98.1%
Consensus $22.50 vs current $11.36